0001193125-16-743872.txt : 20161021 0001193125-16-743872.hdr.sgml : 20161021 20161021163201 ACCESSION NUMBER: 0001193125-16-743872 CONFORMED SUBMISSION TYPE: SC TO-C PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20161021 DATE AS OF CHANGE: 20161021 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Everyday Health, Inc. CENTRAL INDEX KEY: 0001358483 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC TO-C SEC ACT: 1934 Act SEC FILE NUMBER: 005-88533 FILM NUMBER: 161946536 BUSINESS ADDRESS: STREET 1: 345 HUDSON STREET STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 718-797-0722 MAIL ADDRESS: STREET 1: 345 HUDSON STREET STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: WATERFRONT MEDIA INC DATE OF NAME CHANGE: 20060405 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: J2 GLOBAL, INC. CENTRAL INDEX KEY: 0001084048 STANDARD INDUSTRIAL CLASSIFICATION: TELEGRAPH & OTHER MESSAGE COMMUNICATIONS [4822] IRS NUMBER: 471053457 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC TO-C BUSINESS ADDRESS: STREET 1: 6922 HOLLYWOOD BLVD STREET 2: LEGAL DEPT - 5TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90028 BUSINESS PHONE: 3238609200 MAIL ADDRESS: STREET 1: 6922 HOLLYWOOD BLVD STREET 2: LEGAL DEPT - 5TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90028 FORMER COMPANY: FORMER CONFORMED NAME: J2 GLOBAL COMMUNICATIONS INC DATE OF NAME CHANGE: 20001221 FORMER COMPANY: FORMER CONFORMED NAME: JFAX COM INC DATE OF NAME CHANGE: 19990413 SC TO-C 1 d277371d8k.htm 8-K 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) October 21, 2016

 

 

j2 Global, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   0-25965   47-1053457

(State or other jurisdiction

of incorporation or organization)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

6922 Hollywood Blvd.

Suite 500

Los Angeles, California 90028

(Address of principal executive offices)

(323) 860-9200

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☒ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 8.01 Other Events.

On October 21, 2016, j2 Global, Inc. ( “j2”) issued a press release announcing the execution of the Agreement and Plan of Merger, dated as of October 21, 2016 (the “Merger Agreement”), by and among Everyday Health, Inc. (“EVDY”), Ziff Davis, LLC, a subsidiary of j2 (“Ziff Davis”), Project Echo Acquisition Corp, a wholly owned subsidiary of Ziff Davis (“Purchaser”) and, solely with respect to Section 9.11, j2, pursuant to which ZD will acquire all of the outstanding shares of EVDY common stock for $10.50 per share. Closing of the transactions contemplated by the Merger Agreement is subject to customary conditions. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Information About Forward-Looking Statements

This document contains forward-looking statements. These statements are based on j2’s estimates and assumptions and are subject to risks and uncertainties. Forward-looking statements include the information concerning j2’s possible or assumed future results of operations and the transactions contemplated by the Merger Agreement. Forward-looking statements also include those preceded or followed by the words “anticipates,” “believes,” “estimates,” “hopes” or similar expressions. j2’s actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including but not limited to the risk that the acquisition will not close when expected or at all; the risk that Ziff Davis’ business and/or EVDY’s business will be adversely impacted during the pendency of or following the acquisition and the risk that the operations of the two companies will not be integrated successfully. For a further list and description of these and other important risks and uncertainties that may affect j2’s future operations, see Part II, Item 1A—“Risk Factors” of the Quarterly Reports on Form 10-Q (if any) j2 has filed or will file hereafter and in Part I, Item 1A—“Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2015 (together, the “Risk Factors”), and the factors discussed in the sections in j2’s Quarterly Reports on Form 10-Q entitled “Quantitative and Qualitative Disclosures About Market Risk.” Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s opinions only as of the date hereof. j2 undertakes no obligation to revise or publicly release the results of any revision to these forward-looking statements. Readers should carefully review the Risk Factors and the risk factors set forth in other documents j2 files from time to time with the United States Securities and Exchange Commission (the “SEC”).

Additional Information

The tender offer described in this communication (the “Offer”) has not yet commenced, and this communication is neither an offer to purchase nor a solicitation of an offer to sell any shares of the common stock of EVDY or any other securities. This communication is for informational purposes only. The Offer is not being made to, nor will tenders be accepted from, or on behalf of, holders of shares in any jurisdiction in which the making of the tender offer or the acceptance thereof would not comply with the laws of that jurisdiction. On the commencement date of the Offer, a tender offer statement on Schedule TO, including an offer to purchase, a letter of transmittal and related documents, will be filed with the SEC. The offer to purchase shares of EVDY common stock will only be made pursuant to the offer to purchase, the letter of transmittal and related documents filed as a part of the Schedule TO. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ BOTH THE TENDER OFFER STATEMENT AND THE SOLICITATION/RECOMMENDATION STATEMENT REGARDING THE OFFER, AS THEY MAY BE AMENDED FROM TIME TO TIME, WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. The tender offer statement will be filed with the SEC by Purchaser, a wholly owned subsidiary of Ziff Davis and Ziff Davis, and the solicitation/recommendation statement will be filed with the SEC by EVDY. Investors and security holders may obtain a free copy of these statements (when available) and other documents filed with the SEC at the website maintained by the SEC at www.sec.gov or by directing such requests to the Information Agent for the tender offer that will be named in the tender offer statement.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
Number

   

Description

99.1    Press Release issued by j2 Global, Inc., dated October 21, 2016

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

j2 Global, Inc.

(Registrant)

Date: October 21, 2016     By:   /s/ Jeremy Rossen
      Jeremy Rossen
      Vice President, General Counsel

INDEX TO EXHIBITS

 

Exhibit
Number

   

Description

99.1    Press Release issued by j2 Global, Inc., dated October 21, 2016
 EX-99.1 2 d277371dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

j2 Global, Inc.’s Ziff Davis Announces Agreement to Acquire Everyday Health

NEW YORK—(BUSINESS WIRE)— j2 Global, Inc. and Ziff Davis, LLC, a leading digital media company in the technology, gaming and lifestyle categories, today announced that Ziff Davis has entered into a definitive merger agreement to acquire Everyday Health, Inc. (NYSE: EVDY), a leading provider of digital health marketing and communications solutions. Under the terms of the agreement, Ziff Davis will acquire Everyday Health for $10.50 per share in cash, representing an approximate enterprise value of $465 million. Ziff Davis comprises the Digital Media Division of j2 Global, Inc.

Under the terms of the merger agreement, Ziff Davis will commence a tender offer to acquire all of the outstanding shares of Everyday Health for $10.50 per share in cash followed by a merger in which each remaining untendered share of Everyday Health common stock would be converted into the right to receive the same $10.50 cash per share consideration as in the tender offer. The transaction is conditioned upon satisfaction of the minimum tender condition, which requires that shares representing more than 50 percent of Everyday Health’s common shares be tendered, and is subject to regulatory approvals and other customary closing conditions.

Information About Forward-Looking Statements

This document contains forward-looking statements. These statements are based on j2’s estimates and assumptions and are subject to risks and uncertainties. Forward-looking statements include the information concerning j2’s possible or assumed future results of operations and the transactions contemplated by the merger agreement. Forward-looking statements also include those preceded or followed by the words “anticipates,” “believes,” “estimates,” “hopes” or similar expressions. j2’s actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including but not limited to the risk that the acquisition will not close when expected or at all; the risk that Ziff Davis’ business and/or Everyday Health’s business will be adversely impacted during the pendency of or following the acquisition and the risk that the operations of the two companies will not be integrated successfully. For a further list and description of these and other important risks and uncertainties that may affect j2’s future operations, see Part II, Item 1A – “Risk Factors” of the Quarterly Reports on Form 10-Q (if any) j2 has filed or will file hereafter and in Part I, Item 1A – “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2015 (together, the “Risk Factors”), and the factors discussed in the sections in j2’s Quarterly Reports on Form 10-Q entitled “Quantitative and Qualitative Disclosures About Market Risk.” Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s opinions only as of the date hereof. j2 undertakes no obligation to revise or publicly release the results of any revision to these forward-looking statements. Readers should carefully review the Risk Factors and the risk factors set forth in other documents j2 files from time to time with the United States Securities and Exchange Commission (the “SEC”).

Additional Information

The tender offer described in this communication (the “Offer”) has not yet commenced, and this communication is neither an offer to purchase nor a solicitation of an offer to sell any shares of the common stock of Everyday Health or any other securities. This communication is for informational purposes only. The Offer is not being made to, nor will tenders be accepted from, or on behalf of, holders of shares in any jurisdiction in which the making of the tender offer or the acceptance thereof would not comply with the laws of that jurisdiction. On the commencement date of the Offer, a tender offer statement on Schedule TO, including an offer to purchase, a letter of transmittal and related documents, will be filed with the SEC. The offer to purchase shares of Everyday Health common stock will only be made pursuant to the offer to purchase, the letter of transmittal and related documents filed as a part of the Schedule TO. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ BOTH THE TENDER OFFER STATEMENT AND THE SOLICITATION/RECOMMENDATION STATEMENT REGARDING THE OFFER, AS THEY MAY BE AMENDED FROM TIME TO TIME, WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. The tender offer statement will be filed with the SEC by Purchaser, a wholly owned subsidiary of Ziff Davis and Ziff Davis, and the solicitation/recommendation statement will be filed with the SEC by Everyday Health. Investors and security holders may obtain a free copy of these statements (when available) and other documents filed with the SEC at the website maintained by the SEC at www.sec.gov or by directing such requests to the Information Agent for the tender offer that will be named in the tender offer statement.

About Ziff Davis, LLC

Ziff Davis, a subsidiary of j2 Global, Inc., is a leading global digital-media company operating in the technology, gaming, entertainment and lifestyle verticals. Its brands – IGN, PCMag, AskMen, Speedtest, Offers, ExtremeTech, Geek, Toolbox, TechBargains, emedia and Salesify – produce and distribute premium content across multiple platforms and devices. It delivers advertising, performance marketing and licensing solutions to thousands of clients worldwide.

About j2 Global

j2 Global, Inc. provides Internet services through two divisions: Business Cloud Services and Digital Media. The Business Cloud Services Division offers Internet fax, virtual phone, hosted email, email marketing, online backup, unified communications and CRM solutions. It markets its services principally under the brand names eFax®, eVoice®, FuseMail®, Campaigner®, KeepItSafe®, Livedrive®, Onebox®, and LiveVault®, and operates a messaging network spanning 50 countries on six continents. The Digital Media Division offers technology, gaming and lifestyle content through its digital properties, which include IGN, PCMag, AskMen, Speedtest, Offers, ExtremeTech, Geek, Toolbox, TechBargains, emedia and Salesify. As of December 31, 2015, j2 had achieved 20 consecutive fiscal years of revenue growth. For more information about j2, please visit www.j2global.com.

About Everyday Health, Inc.

Everyday Health, Inc. (NYSE: EVDY) is a leading provider of digital health marketing and communications solutions. Everyday Health attracts a large and engaged audience of consumers and healthcare professionals to its premier health and wellness properties, and utilizes its data and analytics expertise to deliver highly personalized content experiences and efficient and effective marketing and engagement solutions. Everyday Health enables consumers to manage their daily health and wellness needs, healthcare professionals to stay informed and make better decisions for their patients, and marketers, health payers and providers to communicate and engage with consumers and healthcare professionals to drive better health outcomes. Everyday Health’s content and solutions are delivered through multiple channels, including desktop, mobile web, and mobile phone and tablet applications, as well as video and social media.

Contacts

j2 Global, Inc.

Laura Hinson, 800-577-1790

press@j2.com

Source: j2 Global, Inc.

 

 

Gallery

 

LOGO

 

LOGO

View this news release and multimedia online at:

http://www.businesswire.com/news/home/20161021005489/en

 

LOGO

GRAPHIC 3 g277371g40x44.jpg GRAPHIC begin 644 g277371g40x44.jpg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end GRAPHIC 4 g277371g70v85.jpg GRAPHIC begin 644 g277371g70v85.jpg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end GRAPHIC 5 g277371g76t52.jpg GRAPHIC begin 644 g277371g76t52.jpg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end